Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Clinical trial NCT01367236 · COMPLETED

Trial details

NCT number: NCT01367236
Sponsor: Imperial College London
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Impaired Cognition

Start date: 2013-01-01
Primary completion: 2015-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.